肾脏专题:狼疮性肾炎的治疗现状与争议:来自中国的数据

2017-09-27 余学清 中华医学信息导报

9月12—16日,由中华医学会、中华医学会肾脏病学分会主办,湖北省医学会承办的中华医学会肾脏病学分会2017年学术年会在风景秀美的“江城”武汉顺利召开。本次大会参会人数达到上万人。大会共设讲座200余场,通过大会报告、专题讲座、口头报告以及壁报交流等形式,展开深入的学术交流。本报选择了余学清教授和侯凡凡院士的大会报告摘要,以飨读者。

9月12—16日,由中华医学会、中华医学会肾脏病学分会主办,湖北省医学会承办的中华医学会肾脏病学分会2017年学术年会在风景秀美的“江城”武汉顺利召开。本次大会参会人数达到上万人。大会共设讲座200余场,通过大会报告、专题讲座、口头报告以及壁报交流等形式,展开深入的学术交流。本报选择了余学清教授和侯凡凡院士的大会报告摘要,以飨读者。

狼疮性肾炎在中国汉族人群中患病率较高,是中国大陆继发性肾小球疾病中的首位病因。在不同种族的狼疮性肾炎患者中,患者的临床表型、病理改变、治疗反应及预后有很大的差异。因此,充分利用好中国的临床资源优势,收集和分析中国狼疮性肾炎患者人群可靠的数据及证据,对于进一步改善患者预后,完善和补充国际相关指南的制定有重要价值。

中山大学附属第一医院肾内科通过新一代测序技术对中国汉族狼疮性肾炎患者进行MHC区域捕获测序,发现MHC最强关联信号位于DRB1-DQB1-DQA1区域,其中位于DRB1的第11位氨基酸和DQB1的第45位氨基酸显示强关联。在MHC区还发现另外3个独立信号与狼疮性肾炎相关。蛋白三维结构预测提示:这些氨基酸均位于抗原结合区和β转角等功能性位置。且HLADRB1、HLA-DQB1氨基酸与狼疮性肾炎患者抗心磷脂抗体以及低补体血症等重要临床特征密切相关。以上在中国汉族人狼疮性肾炎患者的早期诊断和治疗干预具有重要意义。

近年来,我们建立了开放、共享的狼疮性肾炎的临床数据库系统(http://LN.medidata.cn)。来自全国29个省区市的共77家单位加入该数据库,纳入了大样本的狼疮性肾炎患者队列人群(HELP,High quality Evidence of Chinese Lupus Nephritis,Clinical Trials.gov ID:NCT03001973)。截至2017年8月15日,数据库共纳入狼疮性肾炎患者5905例,同时建立了患者血、尿、肾组织标本库,是开展大样本狼疮性肾炎临床及遗传学研究的重要基础和宝库。基于上述队列及样本库,研究团队开展了横断面及回顾性的系列队列研究,了解了我国狼疮性肾炎的各项临床及病理特征等临床表型特征,及伴有不同临床及病理特征的狼疮性肾炎患者的肾脏及存活预后。系列研究结果发现:伴有IgG亚型抗心磷脂抗体阳性、ANCA阳性、SSA/SSB阳性、合并AKI、乙型病毒性肝炎、不同比例的新月体及肾间质浸润的炎症细胞等特征与狼疮性肾炎患者的预后密切相关。上述研究结果,将为我们未来制定相关的防治策略提供重要依据。

近年来,中国学者还开展了多项大型狼疮性肾炎的RCT研究,为中国乃至全世界狼疮性肾炎患者提供了科学、有效、安全的治疗新措施。

我们相信,通过严谨、认真、充分、合理地利用我国患者的临床资源,从遗传学研究、队列研究、RCT研究等多层次出发,精准预防、预测和治疗的多角度结合,将为狼疮性肾炎的防治提供更多高水平的证据。这些大样本的狼疮性肾炎临床研究无疑会直接惠及我国及世界广大狼疮性肾炎患者,并推进我国该领域临床、科研水平不断进步和提高。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2019451, encodeId=fb2820194514d, content=<a href='/topic/show?id=e19b646e254' target=_blank style='color:#2F92EE;'>#治疗现状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64672, encryptionId=e19b646e254, topicName=治疗现状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jul 01 06:06:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707450, encodeId=41261e0745019, content=<a href='/topic/show?id=25df20e54dc' target=_blank style='color:#2F92EE;'>#专题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20754, encryptionId=25df20e54dc, topicName=专题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f4231418733, createdName=108807375_62823137, createdTime=Fri May 25 00:06:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387231, encodeId=1379138e231ad, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532235, encodeId=e1741532235fe, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248254, encodeId=dfdb248254d1, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Sep 27 18:47:10 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248235, encodeId=e33a2482359d, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Sep 27 18:29:21 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2019451, encodeId=fb2820194514d, content=<a href='/topic/show?id=e19b646e254' target=_blank style='color:#2F92EE;'>#治疗现状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64672, encryptionId=e19b646e254, topicName=治疗现状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jul 01 06:06:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707450, encodeId=41261e0745019, content=<a href='/topic/show?id=25df20e54dc' target=_blank style='color:#2F92EE;'>#专题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20754, encryptionId=25df20e54dc, topicName=专题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f4231418733, createdName=108807375_62823137, createdTime=Fri May 25 00:06:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387231, encodeId=1379138e231ad, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532235, encodeId=e1741532235fe, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248254, encodeId=dfdb248254d1, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Sep 27 18:47:10 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248235, encodeId=e33a2482359d, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Sep 27 18:29:21 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2019451, encodeId=fb2820194514d, content=<a href='/topic/show?id=e19b646e254' target=_blank style='color:#2F92EE;'>#治疗现状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64672, encryptionId=e19b646e254, topicName=治疗现状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jul 01 06:06:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707450, encodeId=41261e0745019, content=<a href='/topic/show?id=25df20e54dc' target=_blank style='color:#2F92EE;'>#专题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20754, encryptionId=25df20e54dc, topicName=专题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f4231418733, createdName=108807375_62823137, createdTime=Fri May 25 00:06:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387231, encodeId=1379138e231ad, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532235, encodeId=e1741532235fe, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248254, encodeId=dfdb248254d1, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Sep 27 18:47:10 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248235, encodeId=e33a2482359d, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Sep 27 18:29:21 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2019451, encodeId=fb2820194514d, content=<a href='/topic/show?id=e19b646e254' target=_blank style='color:#2F92EE;'>#治疗现状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64672, encryptionId=e19b646e254, topicName=治疗现状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jul 01 06:06:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707450, encodeId=41261e0745019, content=<a href='/topic/show?id=25df20e54dc' target=_blank style='color:#2F92EE;'>#专题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20754, encryptionId=25df20e54dc, topicName=专题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f4231418733, createdName=108807375_62823137, createdTime=Fri May 25 00:06:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387231, encodeId=1379138e231ad, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532235, encodeId=e1741532235fe, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248254, encodeId=dfdb248254d1, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Sep 27 18:47:10 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248235, encodeId=e33a2482359d, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Sep 27 18:29:21 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-29 villahu
  5. [GetPortalCommentsPageByObjectIdResponse(id=2019451, encodeId=fb2820194514d, content=<a href='/topic/show?id=e19b646e254' target=_blank style='color:#2F92EE;'>#治疗现状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64672, encryptionId=e19b646e254, topicName=治疗现状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jul 01 06:06:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707450, encodeId=41261e0745019, content=<a href='/topic/show?id=25df20e54dc' target=_blank style='color:#2F92EE;'>#专题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20754, encryptionId=25df20e54dc, topicName=专题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f4231418733, createdName=108807375_62823137, createdTime=Fri May 25 00:06:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387231, encodeId=1379138e231ad, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532235, encodeId=e1741532235fe, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248254, encodeId=dfdb248254d1, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Sep 27 18:47:10 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248235, encodeId=e33a2482359d, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Sep 27 18:29:21 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 中医痴

    不错的.学习了.谢谢分享.

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2019451, encodeId=fb2820194514d, content=<a href='/topic/show?id=e19b646e254' target=_blank style='color:#2F92EE;'>#治疗现状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64672, encryptionId=e19b646e254, topicName=治疗现状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jul 01 06:06:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707450, encodeId=41261e0745019, content=<a href='/topic/show?id=25df20e54dc' target=_blank style='color:#2F92EE;'>#专题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20754, encryptionId=25df20e54dc, topicName=专题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f4231418733, createdName=108807375_62823137, createdTime=Fri May 25 00:06:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387231, encodeId=1379138e231ad, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532235, encodeId=e1741532235fe, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Fri Sep 29 09:06:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248254, encodeId=dfdb248254d1, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Wed Sep 27 18:47:10 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248235, encodeId=e33a2482359d, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Wed Sep 27 18:29:21 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 thlabcde

    好资料学习了!

    0

相关资讯

J Am Soc Nephrol:研究发现,呼吸脏空气会伤害肾脏,导致心脏病、中风、癌症、哮喘和慢性阻塞性肺疾病

外空气污染长期以来与主要的健康状况有关,如心脏病、中风、癌症、哮喘和慢性阻塞性肺疾病。根据圣路易斯华盛顿大学医学院和退伍军人事务部圣路易斯卫生保健系统的研究,现在一项新的研究将肾脏疾病列入名单。

这才是真闺蜜:赛琳娜获好友捐肾 可器官短缺在美国依然闹心

足够幸运的赛琳娜获得了好友捐赠的肾脏。但是与中国类似的是,更多的美国人在苦苦等待器官捐献手术,更不要提其背后接踵而至的庞大医疗费用。动物器官移植会是一个良好的解决方案么?

Kidney int:什么!肾脏对电解质的作用居然也有遗传性!

肾脏对电解质的处理对于维持体内平衡必不可少的。然而,目前对这一过程的遗传性以及基因发现的第一步仍然知之甚少。近期,为了深入研究这一过程,一项发表在杂志Kidney int上的基于人群的研究评估了血清浓度、尿液排泄、肾清除以及钠、钾、镁、钙、磷酸盐和氯化物的排泄分数的遗传力。此项研究从洛桑、日内瓦和瑞士伯尔尼的一般人群中随机抽取了核心家庭,并在24小时内收集尿液。使用ASSOC程序(S.A.G.E.

Diabetes Obes Metab:2型糖尿病:不同SGLT2抑制剂的肾脏风险几何?

钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂是一种新型的口服降糖药物。2017年8月,发表在《Diabetes Obes Metab》的一项随机对照试验的网络和累积Meta分析调查了2型糖尿病患者SGLT2抑制剂和不良肾脏结局风险之间的相关性。

Kidney Int:慢性肾脏疾病的又一重要信号通路!

近期,一项发表在杂志Kidney Int上的研究评估了在慢性肾脏疾病(CKD)中激活素受体IIA(ActRIIA)的激活。此项研究使用了75天龄的Alport小鼠,通过使用ActRIIA配体捕获RAP-011的方法研究。在小鼠长至200日龄时,有严重的CKD和相关的矿物和骨质疏松症(CKD-MBD),包括骨营养不良、血管钙化、心脏肥大、高磷酸盐血症、甲状旁腺功能亢进、FGF23升高和klotho降

Diabetes Care:1型糖尿病对肾脏的影响你知道么?

大多数人认为,只有少数1型糖尿病患者(T1D)会发展为晚期肾脏疾病,并且在男性患者中发病率较高,年龄较小的患者发生率较低。然而,直到最近发现,由于只有较少的T1D患者幸存到老年,因此,其长期风险尚不清楚。近期,一项发表在杂志Diabetes Care上的研究评估了在1950-1980年间(n = 932;平均基线年龄29岁,持续19年)诊断的儿童T1D队列中的50年累积肾脏并发症风险。受试者中有1